Press Releases Year All Years 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility Mar 04, 2019 7:00am EST Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development Feb 25, 2019 4:05pm EST Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine Feb 20, 2019 7:00am EST Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018 Feb 19, 2019 7:00am EST Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019 Feb 14, 2019 7:00am EST Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville Feb 11, 2019 7:00am EST Recro Pharma Amends Athyrium Credit Facility Jan 02, 2019 7:00am EST Recro Pharma Amends IV Meloxicam License Agreement with Alkermes Dec 21, 2018 7:00am EST Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology Dec 10, 2018 7:00am EST Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia Nov 14, 2018 7:00am EST Prev 1 2 3 4 5 6 7 8 9 10 ...15 Next
Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility Mar 04, 2019 7:00am EST
Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development Feb 25, 2019 4:05pm EST
Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine Feb 20, 2019 7:00am EST
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018 Feb 19, 2019 7:00am EST
Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019 Feb 14, 2019 7:00am EST
Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville Feb 11, 2019 7:00am EST
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology Dec 10, 2018 7:00am EST
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia Nov 14, 2018 7:00am EST
